Literature DB >> 35567632

PEG-mesoporous material modified by superparamagnetic nanoparticles as a delivery system of cefotaxime.

Amin Salehi1, Mohsen Behpour2, Daryoush Afzali3.   

Abstract

The fight against infectious bacterial diseases has been taking major steps forward by designing new nanodrugs and nanoscale biological carriers with unique physicochemical properties. Here, polyethylene glycol (PEG)-silica mesoporous material/superparamagnetic CuFe2O4 nanoparticle nanocomposite was synthesized using a facile chemical approach, and proposed as a carrier for the delivery of cefotaxime (CTX) drug. The resulting nanocomposite material and nanocomposite CTX drug carrier were characterized by different techniques. Antibacterial activity of the nanocomposite drug carrier was investigated against E.coli and S. aureus bacteria, and compared with that of commercial CTX drug. It was found that the minimum inhibitory concentrations of the nanocomposite drug carrier (1.25 and 5 μg/mL) were significantly less than those of the commercial drug (10 and 80 μg/mL) against the bacteria. Furthermore, enhanced performance of the nanocomposite CTX carrier for both the Gram-negative and Gram-positive bacteria was evidenced.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bacterial resistance; Cefotaxime; Drug delivery system; E. coli; S. aureus; Superparamagnetic nanoparticles

Mesh:

Substances:

Year:  2022        PMID: 35567632     DOI: 10.1007/s00203-022-02937-3

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  2 in total

Review 1.  Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method.

Authors:  J J Biemer
Journal:  Ann Clin Lab Sci       Date:  1973 Mar-Apr       Impact factor: 1.256

Review 2.  Threats of antibiotic resistance: an obliged reappraisal.

Authors:  Fernando Baquero
Journal:  Int Microbiol       Date:  2021-05-24       Impact factor: 2.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.